Balanced Health Today

 Affiliates, Vendors , Doctors

LOGIN HERE

Open 10am to 10pm PST
Call Toll Free: 1.888.449.0552
Home
Articles
Blog
Contact Us
Special Offers
 
HYPERBARIC CHAMBER
 
Stroke
Autism
ADD/ADHD
Fibromyalgia
Alzheimer's
Memory Loss
Wounds
Multiple Sclerosis
Cerebral Palsy
Head Injury
Migraines Parkinson’s
Insomnia
Crohn's
Diabetes
 

MEDICARDIUM
 
Bacteria Detox
Fungal Detox
Pharmaceuticals
Detoxification
 

XENEPLEX
 
Bacteria Detox
Fungal Detox
Pharmaceuticals
Detoxification
 

GLYTAMINS
 
Liver Detox
Gallbladder Purge
Kidney Cleanse
Kidney
 

ELLAGICA
 
Anti-viral
Anti-bacterial
Anti-fungal
Anti-parasitical
Anti-cancer
Anti-oxidant
Anti-mutagenic
Cardio protective
 

ENDOSTEROL
 
Prostate
Hair Loss
Circulation
Inflammation
Immune System
Female Health
 

VIBRABOARD
 
Pain Relief
Bone Density
Rehabilitation
Strength Training
Massage
Relaxation
Sensory Integration
 


Home
 

     Hyperbaric Chamber Stroke TBI

 

//www.balancedhealthtoday.com/hyperbaric-chamber.html

Hyperbaric Chamber Stroke

Hyperbaric Oxygen Chambers

The acute inflammatory response plays an important role in secondary brain damage after traumatic brain injury (TBI). Neutrophils provide the main source of matrix metalloproteinases (MMPs) which also play a deleterious role in TBI. Numerous preclinical studies have suggested that hyperbaric oxygen therapy (HBOT) may by beneficial in various noncerebral and cerebral inflammatory diseases.

The goal of this study was to evaluate the effects of HBOT on inflammatory infiltration and the expression of MMPs in correlation with secondary cell death in the rat model of dynamic cortical deformation (DCD).
Twenty animals underwent DCD with subsequent HBOT (2.8 ATA, two sessions of 45 min each); 10 animals: DCD and normobaric oxygenation (1 ATA), 10 animals: not treated after DCD. Cell death was evaluated by TUNEL.

Neutrophils were revealed by myeloperoxidase staining. Immunohistochemical staining for MMP-2 and -9 and tissue inhibitors of MMP-1 (TIMP-1) and -2 was also performed and the results were quantitatively evaluated by image analysis. In the animals treated by HBOT, a significant decrease in the number of TUNEL-positive cells and neutrophilic inflammatory infiltration was seen in comparison with nontreated animals and those treated by normobaric oxygen. The expression of MMP-9 was also significantly lower in the treated group. Staining for MMP-2 and TIMP-2 did not change significantly.

Our results demonstrate that HBOT decreased the extent of secondary cell death and reactive neuroinflammation in the TBI model. The decline of MMP-9 expression after HBOT may also contribute to protection of brain tissue in the perilesional area. Further research should be centred on the evaluation of long-term functional and morphological results of HBOT.

Chesapeake, Virginia
Mandurah, Victoria
Bahamas, Nassau
Portsmouth, Virginia
Seattle, Washington
Bundaberg, Queensland
Torrance, California
Poland, Warsaw
Comoros, Moroni (on Grande Comoro)
Abu Dhabi, United Arab Emirates, Abu Dhabi, UAE

//www.balancedhealthtoday.com/products.html
 

Chambers To Choose From

Click on the Picture to Go To the Detailed Page

Free Shipping on all chambers w/in the USA

 23" inch Chamber $5,495.00 28" Chamber $9,495.00 28" Military Chamber $5,495.00
  40 inch Chamber $15,995.00 40 inch Vertical  $12,995.00 Flexilite Double Bag Chamber
Double bag Hyperbaric Oxygen Chamber HBOT


PORTABLE HYPERBARIC OXYGEN CHAMBERS

Equipment Financing
Equipment Financing Partner of Balanced Health Today


Balanced Health Today
355 Hukililke Street ( suite 206)
Kahului, Hi 96732
//www.BalancedHealthToday.com
info@BalancedHealthToday.com
888.449.0552